NCAM1 and neoplasm: A significant treatment interaction between a high ratio of CD56+ NK/NKT cells in relation to the sum of CD68+ and CD1a+ cells were seen in the whole cohort (p = 0.007) and in PB-type tumours (p = 0.012), but not in I-type tumours (data not shown).